explore -WSS

explore

author：hotspot 2025-09-14 11:46:31 - browse：172

NIH headquarters — NIH research fellows want to unionize, in large part because they want a raise. Will that mean less money for grants? Lydia Polimeni/NIH

Several thousand research fellows at the National Institutes of Health want to unionize, in large part because they want to raise their pay stipends to something resembling a living wage near the agency headquarters in Bethesda, Md. But with a Congress that is looking on in suspicion at the NIH’s research and a debt ceiling deal that limits budget increases, where is the money going to come from?

Unlike private companies, federal agencies can’t always just give raises. This varies widely across the government, and from position to position. NIH trainees actually have it better than most, because they aren’t subject to the rigid federal pay scale that governs how much most people working in the administration can make. That doesn’t mean, however, that there’s always money for raises. It’s Congress, not the NIH itself, that sets the agency’s budget.

Finding money for raises, therefore, necessarily means taking money from somewhere else, said Richard Freeman, a professor of economics at Harvard.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Why CTE doesn’t keep Americans from enjoying the Super Bowl

knowledge

WSS

Top private equity targets in 2023: cardiology, clinical trials, lasers

Life science postdocs should get big pay hike, NIH panel says

A preacher's new calling: Diversifying neuroscience research

A single Democrat is willing to weaken Medicare negotiation power

Arena BioWorks launches in Cambridge to speed drug discovery

A preacher's new calling: Diversifying neuroscience research

leisure time

explore

hotspot

Alkermes shareholders re

Hospital chaplains balance Covid safety with patients’ spiritual needs

The cancer drug shortage isn’t new — and neither are the solutions

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Cancer drug shortages should be causing more outrage

At JPM 2024, hospital systems pitch financial strength to investors

At least 13 dead in Texas as scorching temps continue

STAT Virtual Event: JPM Recap, Live!

Wildfire smoke exposes gaps in outdoor worker protections

Adopting new red light myopia treatments may be short

entertainment

Arena BioWorks launches in Cambridge to speed drug discovery

American taxpayers paid $1.8 trillion in health care costs in 2022

Ascension's ugly legal battle over care for poor patients in Texas

Gene therapy denied for Afghan refugee whose father aided U.S.

A protest over insulin prices is seen as a fight for life

A preacher's new calling: Diversifying neuroscience research

hotspot

knowledge

knowledge

leisure time